Zumarán Consuelo C, Parra Marcelo V, Olate Sergio A, Fernández Eduardo G, Muñoz Francisco T, Haidar Ziyad S
BioMAT'X, Facultad de Odontología, Universidad de los Andes, Santiago 7550000, Chile.
CEMyQ, Facultad de Odontología, Universidad de La Frontera, Temuco 4780000, Chile.
Materials (Basel). 2018 Jul 26;11(8):1293. doi: 10.3390/ma11081293.
Platelet-Rich fibrin (PRF) is a three-dimensional (3-D) autogenous biomaterial obtained via simple and rapid centrifugation from the patient's whole blood samples, without including anti-coagulants, bovine thrombin, additives, or any gelifying agents. At the moment, it is safe to say that in oral and maxillofacial surgery, PRFs (particularly, the pure platelet-rich fibrin or P-PRF and leukocyte and platelet-rich fibrin or L-PRF sub-families) are receiving the most attention, essentially because of their simplicity, cost-effectiveness, and user-friendliness/malleability; they are a new "revolutionary" step in second-generation therapies based on platelet concentration, indeed. Yet, the clinical effectiveness of such surgical adjuvants or regenerative platelet concentrate-based preparations continues to be highly debatable, primarily as a result of preparation protocol variability, limited evidence-based clinical literature, and/or poor understanding of bio-components and clinico-mechanical properties. To provide a practical update on the application of PRFs during oral surgery procedures, this critical review focuses on evidence obtained from human randomized and controlled clinical trials only. The aim is to serve the reader with current information on the clinical potential, limitations, challenges, and prospects of PRFs. Accordingly, reports often associate autologous PRFs with early bone formation and maturation; accelerated soft-tissue healing; and reduced post-surgical edema, pain, and discomfort. An advanced and original tool in regenerative dentistry, PRFs present a strong alternative and presumably cost-effective biomaterial for oro-maxillo-facial tissue (soft and hard) repair and regeneration. Yet, preparation protocols continue to be a source of confusion, thereby requiring revision and standardization. Moreover, to increase the validity, comprehension, and therapeutic potential of the reported findings or observations, a decent analysis of the mechanico-rheological properties, bio-components, and their bioactive function is eagerly needed and awaited; afterwards, the field can progress toward a brand-new era of "super" oro-dental biomaterials and bioscaffolds for use in oral and maxillofacial tissue repair and regeneration, and beyond.
富血小板纤维蛋白(PRF)是一种三维(3-D)自体生物材料,通过简单快速离心从患者全血样本中获得,不包含抗凝剂、牛凝血酶、添加剂或任何凝胶剂。目前,可以肯定地说,在口腔颌面外科中,PRF(特别是纯富血小板纤维蛋白或P-PRF以及富白细胞和血小板纤维蛋白或L-PRF亚家族)受到的关注最多,主要是因为它们操作简单、成本效益高且使用方便/可塑性强;事实上,它们是基于血小板浓缩的第二代治疗方法中的一个新的“革命性”步骤。然而,这种手术辅助剂或基于再生血小板浓缩物的制剂的临床有效性仍然存在很大争议,主要原因是制备方案的变异性、基于证据的临床文献有限,和/或对生物成分和临床力学性能的了解不足。为了提供关于PRF在口腔外科手术中应用的实用更新,本综述仅关注从人类随机对照临床试验中获得的证据。目的是为读者提供关于PRF的临床潜力、局限性、挑战和前景的当前信息。因此报告经常将自体PRF与早期骨形成和成熟、加速软组织愈合以及减轻术后水肿、疼痛和不适联系起来。作为再生牙科中的一种先进且独特的工具,PRF为口腔颌面组织(软硬组织)的修复和再生提供了一种强大的替代材料,并且可能具有成本效益。然而,制备方案仍然是一个令人困惑的来源,因此需要修订和标准化。此外,为了提高所报告的研究结果或观察结果的有效性、理解性和治疗潜力,迫切需要并期待对其力学流变学特性、生物成分及其生物活性功能进行恰当分析;之后,该领域才能迈向一个全新的“超级”口腔牙科生物材料和生物支架时代,用于口腔颌面组织修复和再生以及其他领域。